A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL
Sign Up to like & getrecommendations! Published in 2022 at "Journal for Immunotherapy of Cancer"
DOI: 10.1136/jitc-2021-003882
Abstract: Background In lymphoid malignancies, the introduction of chimeric antigen receptor T (CAR-T) cells and bispecific antibodies (bsAbs) has achieved remarkable clinical success. However, such immunotherapeutic strategies are not yet established for acute myeloid leukemia (AML),… read more here.
Keywords: aml; cln 049; novel igg; treatment ... See more keywords